GI side effects are some of the most common for semaglutide, with diarrhea occurring for about 30% of semaglutide users, vomiting for 24.5%, and nausea for about 43.9%
Mochi is also the best tirzepatide value at $278/mo vs MEDVi ($499) and Eden ($329)
This receptor is expressed on pituitary somatotrophs and, when started, boosts growth hormone release through a pathway distinct from GHRH
Ongoing research is crucial to better understand the relationship between semaglutide and anterior ischemic optic neuropathy, as well as to develop strategies that reduce the risk of vision loss in patients using weight loss drugs

Pre-existing risk factors for gallstone disease include: Female sex : Women are two to three times more likely to develop gallstones than men, particularly during reproductive years due to hormonal influences Age over 40 years : Gallstone prevalence increases progressively with age Obesity : Higher body mass index correlates with increased gallstone risk, creating a paradox where the condition being treated is itself a risk factor Rapid weight loss history : Previous episodes of quick weight reduction may indicate susceptibility Pregnancy or recent pregnancy : Hormonal changes affect bile composition and gallbladder motility Family history : Genetic factors contribute to gallstone formation Certain ethnicities : Native American and Hispanic populations have higher gallstone prevalence Metabolic syndrome and diabetes : These conditions are associated with altered bile metabolism The rate and magnitude of weight loss during semaglutide treatment significantly influence gallbladder complication risk
